Jasper Therapeutics, Inc. (NASDAQ:JSPR) Receives $62.22 Average Target Price from Analysts
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) has been given an average recommendation of “Buy” by the ten brokerages that are presently covering the company, MarketBeat reports. Ten research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have updated their coverage on the stock […]
Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) has been given an average recommendation of “Buy” by the ten brokerages that are presently covering the company, MarketBeat reports. Ten research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have updated their coverage on the stock […]
